{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:30:20Z","timestamp":1786649420918,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To assess the patient barriers to adherence with corticosteroid eye drops in patients with ocular inflammatory disorders across the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was a multicenter study of adult and pediatric patients with uveitis undergoing treatment with corticosteroid eye drops. Sites included the Johns Hopkins Wilmer Eye, the University of Texas at Austin, the University of Wisconsin-Madison, the University of Minnesota, the Minneapolis Veterans Administration Hospital, and the Washington University of St. Louis. Eligible patients completed a self-reporting survey to assess barriers to adherence with corticosteroid eye drops.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The survey was completed fully by 94 subjects and partially by 20 (115 in total), of whom were 66% White, 60% female, and 47% had a college or advanced degree. While some patients (5.5%,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 6) self-reported never taking their corticosteroid eye drops as prescribed, most reported taking the drops as directed (54.1%,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 59) or at least 90% of the time (29.4%,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 32). Reasons for nonadherence were explored: 56% of patients used a corticosteroid eye drop more than once a day, and 13% found frequency a limitation to adherence. Many patients had polypharmacy, 43% took 4 or more medications, and 50% took 1 or more drops in addition to a corticosteroid eye drop. Patients also reported difficulty reading the writing on drop bottles (39%) and poor vision limiting application into the eye (17%). Almost a quarter (24%) of patients occasionally ran out of their drop before the next refill. Most patients did not report cost (98%) or insurance loss (97%) as a barrier to obtaining a refill.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Barriers to corticosteroid eye drop treatments for ocular inflammatory disease include difficulty with medication frequency, polypharmacy, medication administration, missing refills, and running out of medication early. Addressing these barriers may improve adherence with corticosteroid eye drops to achieve treatment goals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/joco.joco_239_24","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T14:00:53Z","timestamp":1766152853000},"page":"240-246","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Barriers to Adherence with Corticosteroid Eye Drops in Patients with Uveitis"],"prefix":"10.4103","volume":"37","author":[{"given":"Karen","family":"Sun","sequence":"first","affiliation":[{"name":"Georgetown School of Medicine, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayna","family":"Marshall","sequence":"additional","affiliation":[{"name":"Drexel University College of Medicine, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Frankland","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Washington University in St. Louis School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Montana","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Washington University in St. Louis School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Crowell","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen R.","family":"Armbrust","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Minnesota, Minneapolis, MN, USA"},{"name":"Department of Ophthalmology, Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kopplin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Wisconsin Madison School of Medicine and Public Health, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Berkenstock","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"R1-20251222","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00163549","article-title":"The natural history of uveitis","volume":"14","author":"Nussenblatt","year":"1990","journal-title":"Int Ophthalmol"},{"key":"R2-20251222","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ophtha.2011.07.027","article-title":"Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: The multicenter uveitis steroid treatment trial","volume":"118","author":"Kempen","year":"2011","journal-title":"Ophthalmology"},{"key":"R3-20251222","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/eye.2015.269","article-title":"Visual outcomes and ocular morbidity of patients with uveitis referred to a tertiary center during first year of follow-up","volume":"30","author":"Groen","year":"2016","journal-title":"Eye (Lond)"},{"key":"R4-20251222","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1111\/aos.12987","article-title":"Direct and indirect resource use, healthcare costs and work force absence in patients with non-infectious intermediate, posterior or panuveitis","volume":"94","author":"Thorne","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"R5-20251222","doi-asserted-by":"crossref","first-page":"m4979","DOI":"10.1136\/bmj.m4979","article-title":"Uveitis for the non-ophthalmologist","volume":"372","author":"Burkholder","year":"2021","journal-title":"BMJ"},{"key":"R6-20251222","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R7-20251222","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40265-020-01314-y","article-title":"Uveitis therapy: The corticosteroid options","volume":"80","author":"Valdes","year":"2020","journal-title":"Drugs"},{"key":"R8-20251222","doi-asserted-by":"crossref","first-page":"334.e1","DOI":"10.1016\/j.jaapos.2019.08.280","article-title":"The effect of patient compliance on remission rates in pediatric noninfectious uveitis","volume":"23","author":"Ashkenazy","year":"2019","journal-title":"J AAPOS"},{"key":"R9-20251222","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2013 A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R10-20251222","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"R11-20251222","doi-asserted-by":"crossref","first-page":"e084","DOI":"10.1097\/pq9.0000000000000084","article-title":"Assessing barriers to uveitis screening in patients with juvenile idiopathic arthritis through semi-structured interviews","volume":"3","author":"Ballenger","year":"2018","journal-title":"Pediatr Qual Saf"},{"key":"R12-20251222","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2009.08.011","article-title":"Are you compliant with addressing glaucoma adherence?","volume":"149","author":"Mansberger","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R13-20251222","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/jgs.13153","article-title":"Health outcomes associated with polypharmacy in community-dwelling older adults: A systematic review","volume":"62","author":"Fried","year":"2014","journal-title":"J Am Geriatr Soc"},{"key":"R14-20251222","doi-asserted-by":"crossref","first-page":"e000649","DOI":"10.1136\/bmjophth-2020-000649","article-title":"Anxiety and depression in inflammatory eye disease: Exploring the potential impact of topical treatment frequency as a putative psychometric item","volume":"6","author":"Vakros","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"key":"R15-20251222","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s40266-018-0545-3","article-title":"A glimpse into uveitis in the aging eye: Pathophysiology, clinical presentation and treatment considerations","volume":"35","author":"Akinsoji","year":"2018","journal-title":"Drugs Aging"},{"key":"R16-20251222","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1869-5760-3-64","article-title":"Healthcare costs and utilization for privately insured patients treated for non-infectious uveitis in the USA","volume":"3","author":"Chu","year":"2013","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R17-20251222","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.ophtha.2019.04.018","article-title":"Comparison of United States and international ophthalmic drug pricing","volume":"126","author":"Gong","year":"2019","journal-title":"Ophthalmology"},{"key":"R18-20251222","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF03256159","article-title":"Cost savings associated with filling a 3-month supply of prescription medicines","volume":"7","author":"Rabbani","year":"2009","journal-title":"Appl Health Econ Health Policy"},{"key":"R19-20251222","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s11606-013-2546-6","article-title":"Potential savings associated with drug substitution in Medicare Part D: The translating research into action for diabetes (TRIAD) study","volume":"29","author":"Duru","year":"2014","journal-title":"J Gen Intern Med"},{"key":"R20-20251222","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/18-084","article-title":"Evaluation of a novel financial navigator pilot to address patient concerns about medical care costs","volume":"23","author":"Banegas","year":"2019","journal-title":"Perm J"},{"key":"R21-20251222","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/eye.2008.103","article-title":"Barriers to adherence with glaucoma medications: A qualitative research study","volume":"23","author":"Lacey","year":"2009","journal-title":"Eye (Lond)"},{"key":"R22-20251222","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1080\/09273948.2019.1699122","article-title":"Adherence to topical medication in patients with inflammatory eye disease","volume":"29","author":"Javidi","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"R24-20251222","doi-asserted-by":"crossref","first-page":"e0212007","DOI":"10.1371\/journal.pone.0212007","article-title":"Improving eye-drop administration skills of patients \u2013A multicenter parallel-group cluster-randomized controlled trial","volume":"14","author":"Lampert","year":"2019","journal-title":"PLoS One"},{"key":"R25-20251222","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/09273948.2020.1861304","article-title":"Health literacy, medication adherence, and quality of life in patients with uveitis","volume":"30","author":"Mueller","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"R26-20251222","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/09273948.2017.1413396","article-title":"Readability assessment of online uveitis patient education materials","volume":"27","author":"Ayoub","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"R27-20251222","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archopht.126.5.718","article-title":"Functional health literacy in patients with glaucoma in urban settings","volume":"126","author":"Juzych","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R28-20251222","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1080\/09273948.2016.1175638","article-title":"Do demographic factors influence uveitis patients' understanding of uveitis?","volume":"25","author":"Papagiannuli","year":"2017","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Journal of Current Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/joco.joco_239_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:53:57Z","timestamp":1786647237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/joco.joco_239_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/joco.joco_239_24","relation":{},"ISSN":["2452-2325"],"issn-type":[{"value":"2452-2325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2024-11-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}